Related Experiment Videos
Sexual functioning in patients with lower urinary tract dysfunction improves after percutaneous tibial nerve
M R van Balken1, H Vergunst, H Verguns
1Department of Urology, Rijnstate Hospital, Arnhem, The Netherlands. mvanbalken@alysis.nl
International Journal of Impotence Research
|March 11, 2006
Summary
Neuromodulative therapy, like percutaneous tibial nerve stimulation (PTNS), significantly improved sexual functioning in patients with lower urinary tract disorders. Improvements were noted in overall satisfaction, libido, and sexual activity frequency.
Area of Science:
- Urology
- Sexual Medicine
Background:
- Lower urinary tract dysfunction (LUTD) significantly impacts patients' quality of life.
- Sexual dysfunction is a common but often overlooked comorbidity in LUTD patients.
Purpose of the Study:
- To evaluate the effect of neuromodulative therapy on sexual functioning in patients with overactive bladder (OAB), chronic pelvic pain, and nonobstructive retention.
- To identify patient subgroups most likely to experience sexual function improvement following treatment.
Main Methods:
- A cohort of 121 patients with LUTD underwent 12 weeks of neuromodulation (percutaneous tibial nerve stimulation, PTNS).
- Standardized questionnaires assessed sexual function before and after treatment.
- Patient demographics, diagnosis, and subjective treatment response were recorded.
Main Results:
- Pre-treatment, 25.3-45.6% of patients reported abnormal sexual function.
- Following PTNS therapy, significant improvements were observed across various sexual function parameters.
- Women, patients with OAB, and subjective treatment responders showed the greatest benefit.
Conclusions:
- Neuromodulative therapy offers a viable treatment option for sexual dysfunction associated with LUTD.
- Successful treatment of lower urinary tract symptoms can lead to meaningful improvements in sexual health.
- Targeted therapy can enhance overall patient well-being by addressing both urinary and sexual health concerns.